UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): ~~February 17~~April 18, 2011

NovaMed, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware	~~0-26625~~	360-~~4116193~~26625	36-4116193
(State or Other Jurisdiction	(Commission	(IRS Employer
(State or Other		(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)
Jurisdiction		File Number)	Identification No.)
333 West Wacker Drive, Suite 1010, Chicago, Illinois		60606
of incorporation)
(Address of Principal Executive Offices)		(Zip Code)

333 West Wacker Drive, Suite 1010, Chicago, Illinois		60606
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code (312) 664-4100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Section 2 7 –- ~~Financial~~Regulation ~~Information~~FD

Item 2 7.~~02 Results~~01. ofRegulation ~~Operations and Financial Condition.~~FD

On ~~February~~ 17April 18, 2011, NovaMed, Inc., ~~issued~~a Delaware corporation (the “Company”), announced that it has scheduled a ~~press~~special ~~release~~meeting ~~announcing~~of its ~~results~~ stockholders for May 4, 2011, to consider and approve the merger contemplated by the Agreement and Plan of ~~operations~~Merger, ~~for~~dated as of January 20, 2011 (the ~~period~~“Merger ~~ended~~Agreement”) ~~December~~among 31the Company, ~~2010~~Surgery Center Holdings, Inc. (“Surgery Partners”), and Wildcat Merger Sub, Inc., a wholly-owned subsidiary of Surgery Partners (“Merger Sub”). In connection therewith, the Company provided notice of an anticipated fundamental change and merger to holders of its convertible senior subordinated notes. A copy of the press release is attached tohereto ~~this~~as ~~Current~~Exhibit 99.1 ~~Report~~and onis ~~Form~~incorporated ~~8-K~~by asreference ~~Exhibit 99~~herein.1.

~~The information~~Section 9 in— ~~this~~Financial ~~Form~~Statements ~~8-K~~ and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.Exhibits

~~Section~~ Item 9.01 – Financial Statements and Exhibits.

~~Item 9.01 Financial Statements and~~ (d) Exhibits

~~(c)~~99.1 ~~Exhibits~~Press Release dated April 18, 2011 of NovaMed, Inc.

	Exhibit Number	Title
	99.1	Press release of NovaMed, Inc. dated February 17, 2011

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	NovaMed, Inc.
Dated: February 17, 2011	By:	/s/ Scott T. Macomber
Dated: April 18, 2011	By:	/s/ Scott T. Macomber
		Scott T. Macomber
		Executive Vice President and Chief Financial Officer

~~EXHIBIT INDEX~~3

Exhibit No.	Exhibit
99.1	Press release of NovaMed, Inc. dated February 17, 2011

EXHIBIT INDEX

99.1

Press Release dated April 18, 2011 of NovaMed, Inc.

Filing Compare · NOVAMED INC